ASP Isotopes (NASDAQ:ASPI) Shares Gap Up – What’s Next?

Shares of ASP Isotopes Inc. (NASDAQ:ASPI) gapped up prior to trading on Tuesday . The stock had previously closed at $7.65, but opened at $7.94. ASP Isotopes shares last traded at $7.53, with a volume of 1,082,124 shares.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ASPI. Canaccord Genuity Group started coverage on shares of ASP Isotopes in a research report on Friday, October 4th. They set a “buy” rating and a $4.50 price objective on the stock. HC Wainwright lowered their price target on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and issued a $4.50 price objective on shares of ASP Isotopes in a report on Friday, October 18th.

ASP Isotopes Price Performance

The company has a market capitalization of $422.63 million, a P/E ratio of -9.70 and a beta of 3.88. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. The firm’s 50-day moving average is $5.05 and its 200-day moving average is $3.89.

Institutional Investors Weigh In On ASP Isotopes

A number of hedge funds have recently modified their holdings of the business. Fielder Capital Group LLC bought a new stake in ASP Isotopes during the second quarter valued at about $55,000. The Manufacturers Life Insurance Company bought a new stake in ASP Isotopes during the 3rd quarter worth approximately $52,000. KKM Financial LLC lifted its holdings in ASP Isotopes by 66.2% during the third quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock valued at $63,000 after purchasing an additional 9,000 shares in the last quarter. Sanctuary Advisors LLC bought a new position in shares of ASP Isotopes in the third quarter worth approximately $66,000. Finally, MetLife Investment Management LLC purchased a new stake in shares of ASP Isotopes in the third quarter worth $88,000. Institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.